NCT06783413

Brief Summary

This study is planned to evaluate the effects of laughter yoga applied to patients with multiple sclerosis on fatigue, sleep quality and psychological well-being. Although there are studies in the national and international literature that separately address the effects of laughter therapy on fatigue, sleep quality and psychological well-being, no studies have been found that address the effects of laughter therapy on fatigue, sleep quality and psychological well-being in patients with multiple sclerosis. This study is expected to make a significant contribution to the literature as it is the first experimental study to evaluate the effects of laughter therapy and laughter yoga applied to patients with multiple sclerosis on fatigue, sleep quality and psychological well-being. It is also thought that this study can guide studies to be conducted with other parameters. This study is planned to evaluate the effects of laughter yoga applied to patients with multiple sclerosis on fatigue, sleep quality and psychological well-being. Research Hypothesis H1: Laughter yoga reduces the fatigue level of multiple sclerosis patients compared to the control group. H2: Laughter yoga increases the sleep quality of multiple sclerosis patients compared to the control group. H3: Laughter yoga increases the effect of laughter yoga on psychological well-being of multiple sclerosis patients compared to the control group. Variables of the Study Dependent Variables: Introductory Information Form, Fatigue Severity Scale-YSQ, Pittsburgh Sleep Quality Index (PSQI), Psychological Well-Being Scale (PWSS) and Expanded Disability Status Scale (EDSS) will be used. Independent Variables: Laughter Yoga

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 20, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

April 15, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2025

Completed
Last Updated

December 31, 2025

Status Verified

December 1, 2025

Enrollment Period

2 months

First QC Date

January 14, 2025

Last Update Submit

December 24, 2025

Conditions

Keywords

Multiple SclerosisLaughter YogaFatigueSleep QualityPsychological Well-BeingNursing

Outcome Measures

Primary Outcomes (1)

  • Fatigue

    Change in fatigue levels measured using the Fatigue Severity Scale (FSS). Participants' fatigue scores will be assessed at baseline and at the end of 6 weeks to assess the effectiveness of laughter yoga.

    6 weeks

Secondary Outcomes (1)

  • Sleep Quality

    6 weeks

Other Outcomes (1)

  • Effect on Psychological Well-Being

    6 weeks

Study Arms (2)

Intervention Group( Laughter Yoga Group)

EXPERIMENTAL

This group will participate in laughter yoga sessions twice a week for 30 minutes. These sessions include breathing techniques, laughter exercises and relaxation activities. The intervention period is 6 weeks in total.

Behavioral: Intervention group (Laughter Yoga)

No Intervention (Control Group)

OTHER

Participants in the control group will undergo standard care procedures without receiving any intervention. The results will be evaluated for comparison purposes.

Other: Control group

Interventions

Laughter yoga is a practice that includes physical laughing exercises and breathing techniques. Sessions will be conducted as group therapy with a trained guide. The intervention will be applied to evaluate changes in participants' fatigue, sleep quality and psychological well-being.

Intervention Group( Laughter Yoga Group)

Participants in the control group will continue to receive their current standard of care and will not receive any additional interventions.

No Intervention (Control Group)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between the ages of 18-65
  • Being literate
  • Being diagnosed with MS
  • Not having had an attack in the last month
  • Being under 6.5 on the Expanded Disability Status Scale (EDSS)
  • Not having a diagnosis of cognitive or mental disorder
  • Being willing to participate in the study
  • The patient has internet access
  • Not having incontinence

You may not qualify if:

  • Having a diagnosis of cognitive or mental disorder
  • Having communication problems
  • Having previously experienced laughter yoga
  • Having a history of surgery in the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tokat Gaziosmanpaşa University

Tokat Province, 60500, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Multiple SclerosisFatigueSleep Initiation and Maintenance DisordersPsychological Well-Being

Interventions

Laughter TherapyControl Groups

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersMental DisordersPersonal SatisfactionBehavior

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants will not know which group they are in. The person who analyzes the data obtained at the end of the study will not know
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized-controlled
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sponsor-Investigator

Study Record Dates

First Submitted

January 14, 2025

First Posted

January 20, 2025

Study Start

April 15, 2025

Primary Completion

May 30, 2025

Study Completion

May 30, 2025

Last Updated

December 31, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share
Shared Documents
CSR

Locations